Wan Hee Yoon
@wanheeyoon.bsky.social
Exploring Mendelian neurological diseases with a focus on mitochondrial roles in neurodevelopment. Associate Professor of the Aging & Metabolism Research Program at the OMRF
Looking for a passionate researcher to join our team and study neurological diseases using hiPSC models!!
omrf.org/about-omrf/h...
omrf.org/about-omrf/h...
Careers at OMRF
Innovation. It’s in our DNA. Is it in yours?
If you have big ideas and passion and want to learn, grow and make a difference, join our OMRF team. Help us make discoveries that change people’s lives.
...
omrf.org
July 29, 2025 at 3:26 PM
Looking for a passionate researcher to join our team and study neurological diseases using hiPSC models!!
omrf.org/about-omrf/h...
omrf.org/about-omrf/h...
Outstanding discovery! Unveiling a novel role of the mitochondrial solute carrier SLC25A38 in mitochondrial pyridoxal 5'-phosphate (Vitamin B6) accumulation, identified through a CRISPR/Cas9-mediated screen. Great work!
Here is a quick thread to promote my research! After years of dedicated research, I'm thrilled to share our article just published at Nature Communications :)
www.nature.com/articles/s41...
#metabolism #CRISPRscreens #mitochondria
www.nature.com/articles/s41...
#metabolism #CRISPRscreens #mitochondria
SLC25A38 is required for mitochondrial pyridoxal 5’-phosphate (PLP) accumulation
Nature Communications - Pyridoxal 5’-phosphate (PLP, vitamin B6) is crucial for various metabolic processes. Here, the authors identified SLC25A38 as a key regulator of mitochondrial PLP...
www.nature.com
January 25, 2025 at 8:53 PM
Outstanding discovery! Unveiling a novel role of the mitochondrial solute carrier SLC25A38 in mitochondrial pyridoxal 5'-phosphate (Vitamin B6) accumulation, identified through a CRISPR/Cas9-mediated screen. Great work!
CRISPR treatments helped people with either of two heritable blood disorders, sickle-cell disease and β-thalassaemia!
www.nature.com/articles/d41...
www.nature.com/articles/d41...
CRISPR genome-editing grows up: advanced therapies head for the clinic
Gene-editing technologies for cancer and blood disorders are maturing a little more than a year after the first CRISPR drug was approved.
www.nature.com
December 19, 2024 at 9:39 PM
CRISPR treatments helped people with either of two heritable blood disorders, sickle-cell disease and β-thalassaemia!
www.nature.com/articles/d41...
www.nature.com/articles/d41...
Rare diseases are not rare; There is the urgent need for innovative solutions!
chanzuckerberg.com/newsroom/cit...
chanzuckerberg.com/newsroom/cit...
Accelerating Research and Driving Rare Disease Breakthroughs
Citizen Health and CZI partner to empower rare disease patients, accelerate clinical trial launches, and advance drug development.
chanzuckerberg.com
December 7, 2024 at 5:45 PM
Rare diseases are not rare; There is the urgent need for innovative solutions!
chanzuckerberg.com/newsroom/cit...
chanzuckerberg.com/newsroom/cit...
I am honored to receive this prestigious award in honor of Dr. Neufeld, with Dr. Tamar Harel. A heartfelt thank you to
US-Israel Binational Science Foundation.
US-Israel Binational Science Foundation.
November 22, 2024 at 6:39 PM
I am honored to receive this prestigious award in honor of Dr. Neufeld, with Dr. Tamar Harel. A heartfelt thank you to
US-Israel Binational Science Foundation.
US-Israel Binational Science Foundation.
Dr. Hugo Bellen is coming to OMRF and will present his exciting research on Nov. 14!
November 22, 2024 at 6:37 PM
Dr. Hugo Bellen is coming to OMRF and will present his exciting research on Nov. 14!
Congratulations to Jim on his Lifetime Achievement Award! He is an great scientist and mentor, someone I truly aspire to follow in the footsteps of.
November 22, 2024 at 6:36 PM
Congratulations to Jim on his Lifetime Achievement Award! He is an great scientist and mentor, someone I truly aspire to follow in the footsteps of.